Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Peskar, BA; Cawello, W; Rogatti, W; Rudofsky, G.
On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
J Physiol Pharmacol. 1991; 42(3):327-331
PubMed Google Scholar

Leading authors Med Uni Graz: Peskar Bernhard
Altmetrics:
Dimensions Citations:
Plum Analytics:
Abstract:: We have demonstrated recently the formation of a biologically active metabolite of prostaglandin (PG) E1, 13,14-dihydro-PGE1, during intravenous infusions of PGE1 in patients with peripheral arterial occlusive disease. We have now investigated the levels of the immediate precursor of 13,14-dihydro-PGE1, the biologically inactive 15-keto-13,14-dihydro-PGE1, during intravenous administration of 20 micrograms, 40 micrograms or 80 micrograms PGE1 over a period of 60 min to human volunteers. It was found that levels of 15-keto-13,14-dihydro-PGE1, but not those of PGE1 itself, increased in a dose-dependent manner. Thus, increased formation of 13,14-dihydro-PGE1 from 15-keto-13,14-dihydro-PGE1 with increasing doses of PGE1 can be expected to occur. It remains to be investigated, to which extent formation of small amounts of 13,14-dihydro-PGE1 during intravenous infusion of PGE1 could contribute to the therapeutic effects of PGE1 in patients with peripheral arterial occlusive disease.
Find related publications in this database (using NLM MeSH Indexing): Adult -; Alprostadil - blood; Dinoprostone - analogs and derivatives; Dose-Response Relationship, Drug - analogs and derivatives; Humans - analogs and derivatives; Infusions, Intravenous - analogs and derivatives; Male - analogs and derivatives